POLYMED.NS Profit & Loss
Poly Medicure Ltd.
Profit & Loss Balance Sheet Cash Flow
Profit & Loss · 4 years on file
(FY2022-23 to FY2025-26)
· fetched 2026-08-23 23:43
| Line item | FY2022-23 | FY2023-24 | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|---|---|
| Revenue from Operations | ₹1,115.23 Cr. | ₹1,375.80 Cr. | ₹1,669.83 Cr. | ₹1,875.26 Cr. | RevenueFromOperations |
| Gross Revenue (incl. inter-segment) | N/A | N/A | N/A | N/A | SegmentRevenueFromOperations |
| Other Income | ₹36.19 Cr. | ₹58.75 Cr. | ₹89.13 Cr. | ₹120.08 Cr. | OtherIncome |
| Total Income | ₹1,151.42 Cr. | ₹1,434.54 Cr. | ₹1,758.96 Cr. | ₹1,995.34 Cr. | Income |
| Cost of Materials Consumed | ₹424.31 Cr. | ₹464.78 Cr. | ₹571.36 Cr. | ₹599.39 Cr. | CostOfMaterialsConsumed |
| Purchases of Stock-in-Trade | ₹5.21 Cr. | ₹7.02 Cr. | ₹7.94 Cr. | ₹5.06 Cr. | PurchasesOfStockInTrade |
| Changes in Inventories | ₹-23.65 Cr. | ₹10.80 Cr. | ₹-24.61 Cr. | ₹-7.64 Cr. | ChangesInInventoriesOfFinishedGoodsWorkInProgressAndStockInTrade |
| Employee Benefit Expense | ₹202.75 Cr. | ₹245.91 Cr. | ₹301.53 Cr. | ₹402.26 Cr. | EmployeeBenefitExpense |
| Finance Costs | ₹8.84 Cr. | ₹11.30 Cr. | ₹12.00 Cr. | ₹18.29 Cr. | FinanceCosts |
| Depreciation and Amortisation | ₹57.17 Cr. | ₹63.93 Cr. | ₹82.64 Cr. | ₹115.52 Cr. | DepreciationDepletionAndAmortisationExpense |
| Other Expenses | ₹241.22 Cr. | ₹289.06 Cr. | ₹360.77 Cr. | ₹433.88 Cr. | OtherExpenses |
| Total Expenses | ₹915.85 Cr. | ₹1,092.80 Cr. | ₹1,311.62 Cr. | ₹1,566.75 Cr. | Expenses |
| Profit Before Exceptional Items and Tax | ₹235.56 Cr. | ₹341.74 Cr. | ₹447.33 Cr. | ₹428.59 Cr. | ProfitBeforeExceptionalItemsAndTax |
| Exceptional Items | ₹0.00 Cr. | ₹0.00 Cr. | ₹0.00 Cr. | ₹-6.80 Cr. | ExceptionalItemsBeforeTax |
| Profit Before Tax | ₹235.56 Cr. | ₹341.74 Cr. | ₹447.33 Cr. | ₹421.79 Cr. | ProfitBeforeTax |
| Tax Expense | ₹58.21 Cr. | ₹86.01 Cr. | ₹113.96 Cr. | ₹106.74 Cr. | TaxExpense |
| Net Profit (incl. minority interest) | ₹179.28 Cr. | ₹258.26 Cr. | ₹338.56 Cr. | ₹320.73 Cr. | ProfitLossForPeriod |
| Net Profit (to shareholders) | ₹179.28 Cr. | ₹258.26 Cr. | ₹338.56 Cr. | ₹322.14 Cr. | ProfitOrLossAttributableToOwnersOfParent |
| Basic EPS | ₹18.69 | ₹26.92 | ₹34.13 | ₹31.79 | BasicEarningsLossPerShareFromContinuingAndDiscontinuedOperations |
| Diluted EPS | ₹18.67 | ₹26.90 | ₹34.11 | ₹31.75 | DilutedEarningsLossPerShareFromContinuingAndDiscontinuedOperations |
Every figure above is the exact value of the named XBRL element from POLYMED.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).